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Abstract 
Information related to short- and long-term risks of children born to kidney-transplanted 
women remains limited. With the aim of investigating the risk of neonatal complications, and 
the short- and long-term risk of infections in offspring of kidney-transplanted women, all 
children born to kidney-transplanted women in Denmark from 1964 to 2016 were identified 
in a nationwide retrospective matched cohort study. A total of 124 children of kidney-
transplanted women were identified and matched on gender, birth year, and number of 
siblings at birth 1:10 with children born to non-transplanted women identified in the Danish 
general population. Prevalence of low birth weight (37.9%, RR=12.61[95%CI 8.5-18.5]), 
premature birth (46.0%, RR=11.32[95%CI 8.1-15.7]) and malformations (11.3%, 
RR=1.98[95%CI 1.2-3.4]) was increased in children of kidney-transplanted women 
compared with controls. Similarly, prevalence of hospitalization due to infection was 
increased during the first year of life (21.0%, RR=1.94[95% CI 1.3–2.8]), from age one to five 
(34.2%, RR=1.89[95%CI 1.4–2.5]), and overall (41.9%, RR=1.67[95%CI 1.3-2.1]). The risk of 
infection was also higher in children of kidney-transplanted mothers born preterm or with 
low birth weight compared with similar controls. In conclusion, risk of neonatal 
complications, malformations, and both early and late infection was increased in children 
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1. Introduction
Fertility improves within months in women following successful kidney transplantation.1 
Optimal timing of pregnancy following kidney transplantation remains debated. Historically, 
kidney-transplanted women have been advised to postpone pregnancy two years following 
transplantation due to concerns about rejection and allograft function.2,3 A committee 
consensus from the American Society of Transplantation in 2003 recommended that 
pregnancy could be considered after one year following transplantation if the woman has 
had no rejection, had adequate and stable graft function, no risk of infections, no use of 
teratogenic medications and stable immunosuppressive treatment.3,4 Potential risks of 
pregnancy in kidney-transplanted women include pregnancy-related complications (e.g. 
preeclampsia, cesarean section and preterm birth) and potential risk for fetal development 
due to the immunosuppressive treatment.1–3 The risk of graft rejection during pregnancy are 
similar to non-pregnant women4,5 with a rejection rate of approximately 9-14.5%.4 To 
mitigate risk, guidelines advocate adjustment of maintenance immunosuppressive therapy 
in kidney-transplanted women prior to conception and during pregnancy6, with current 
recommendations advocating a combination of azathioprine, maintenance prednisone, and 
either tacrolimus or cyclosporine.7 
Knowledge regarding kidney-transplanted women and pregnancy outcomes is limited. Most 
studies reporting pregnancy outcomes in kidney-transplanted women are small, single-
center based, and retrospective; additionally, existing studies have primarily reported on 
maternal complications and neonatal outcomes such as preterm birth, low birth weight, and 
malformations.5,8,9 Only one study with 28 children of kidney-transplanted women has 
reported on risk of infections during the first year of life.10 The aim of this nationwide 
controlled cohort study was to investigate the risk for neonatal complications and 
malformations with specific emphasis on the short- and long-term risk of infections in 
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2. Materials and Methods
2.1 Data sources
Numerous comprehensive and validated national registers exist in Denmark. All information 
regarding hospitalization, medication, morbidity and mortality is recorded in national 
databases (i.e. The Danish National Patient Register, The Danish National Prescription 
Registry, and The Civil Registration System) under a unique individual central person 
register number permitting cross-referencing of data between registers.
The validated Danish National Register on Regular Dialysis and Transplantation (NRDT) was 
established in 1990, but includes all patients with kidney transplantation since 1964.11 The 
Danish National Patient Register (DNPR) contains information on the date, cause and type of 
all hospitalizations and surgical procedures in Denmark since 1977. All diagnoses from 1977 
to 1994 are registered according to International Classification of Diseases (ICD), Eighth 
Revision, and those from 1994 onward according to ICD-10.12,13
The Danish Medical Birth Register (DMBR) was established in 1973, but contains data on all 
children born in Denmark and their parents from 1954 permitting cross-referencing of data 
between parents and children.14 The register permits cross-referencing of information 
between siblings and extended family. Furthermore, the DMBR contains data on birth 
weight, gestational week and length. The validated Danish National Prescription Register 
contains information on all redemptions of prescriptions in Denmark.15 Outpatient 
pharmacies are mandated by law to register information on all redeemed prescriptions, and 
the register has been shown to be of high-quality from 1995 and onward. Data are registered 
according to the Anatomical Therapeutic Chemical Classification System (ATC).16
2.2 Study population
All children born to kidney-transplanted women between 1964 (when the first kidney-
transplantation was performed in Denmark) and 31st December 2016 were identified in the 
DMBR. Children of kidney-transplanted women were exact matched on gender, birth year, 
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women identified in the Danish general population. Subjects were included at birth and 
followed until the time of an event, emigration, death or the end of the study period (31st 
December 2017).
2.3 Study outcomes
Outcomes were defined based on administrative diagnosis codes identified in the DNPR and 
DMBR relating preterm  birth (birth prior to gestational week 37), malformation 
(malformations in the nervous system, eyes, ears, face, neck, lip, palate, cardiovascular 
system, gastrointestinal system, genital system, urinary system, bones and tissue and 
chromosome anomalies), low birth weight (birth weight < 2500g) and hospitalization due to 
infections. Study outcomes relating to redemptions of a prescription for antibiotic treatment 
were identified in The Danish National Prescription Registry (ATC J01-04). An overview of 
all administrative codes employed is provided in Supplemental Table S1. Outcomes for both 
hospitalizations due to infections and redemption of a prescription for antibiotic treatment 
were evaluated overall (from birth to age 5 years), early (within the first year of life) and late 
(from age 1-5 years).
2.4 Statistical analyses
Continuous variables were compared with the Student’s t-test, and discrete variables with χ2 
test. Risk ratios (RR) were calculated for the binary outcomes premature birth, 
malformation, low birth weight, as well as for hospitalizations due to infections and 
redemptions of a prescription for antibiotic treatment within three age periods (0-1, 0-5 and 
1-5 years). We calculated the difference between exposed and non-exposed children in 
relation to the average number of hospitalizations per child due to infection and the number 
of redeemed prescriptions for antibiotic treatment within the three age periods. Koopman’s 
method was used for uncensored data17 and appropriate methods were used to deal with 
censoring and competing risks where relevant.18,19 Subgroup analyses were performed to 
study the effect of exposure within the population of infants with premature birth, low birth 
weight or born from a mother suffering from diabetes or hypertension. Subgroup analyses 
by time periods (< 1996, 1996-2010, > 2010) and by use of prednisone on risk of infection 
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P-values < 0.05 were considered statistically significant. All analyses were performed using 
SAS Version 9.4 (SAS Institute, NC, USA) or R: A language and environment for statistical 
computing, version 1.1.447 (www.R-project.org The R Foundation).
2.5 Ethics
The project was approved by the Danish Data Protection Agency (Ref no. 2008-58-
0028/2017-182). Use of the NRDT database was approved by The Danish Clinical Registries, 
(RKKP), (Ref no. DNSL-2017-11-17). Pseudo-anonymized data were made accessible at an 
individual level permitting cross-referencing across national registers. Retrospective 
register studies in Denmark do not require approval from ethics committees. All data are 
held by Statistics Denmark, which also has administrative rights of the data. Due to 
legislative restrictions in Denmark on the use of register-based health care data, we are 
unable to publicize results on ‘microdata’ i.e. aggregated data with < 4 cases. 
3. Results
A total of 124 children born to kidney-transplanted women were identified between 1964 
and 2016 (Supplemental Figure S1) and comprised the exposed cohort. A total of 1231 
children of non-transplanted women identified in the Danish general population comprised 
the non-exposed cohort. The match was complete except for nine children. Baseline 
characteristics are shown in Table 1. Median follow-up time was approximately 14 years in 
both groups. The average birth weight was 2421 g in the exposed cohort compared to 3444 g 
in the non-exposed cohort. Supplemental Figure S2 illustrates the distribution curves over 
the birth weight.
Figure 1 shows the outcomes pertaining to neonatal complications. Prevalence and risk 
ratios of premature birth and low birth weight were increased in the exposed cohort. Of 
note, prevalence of premature birth and low birth weight in children of kidney-transplanted 
women were 46.0% (RR 11.3 [95%CI 8.1-15.7]) and 37.9% (RR 12.6 [95%CI 8.5-18.5]), 
respectively. The exposed children observed a significantly 1.98 (95% CI 1.2-3.4) increased 
risk of malformations compared with the non-exposed cohort. Fifty percent of the 
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majority (6 cases) had malformations in relation to the septum (e.g. ventricular septal defect 
and atrial septal defect). No significant differences in infant mortality (death during the first 
year of life) were observed.
Risk ratios for hospitalization due to infection were increased for all periods as shown in 
Figure 2. No significant differences were observed regarding redemptions of prescription for 
antibiotic treatment.
During the first year of life a total of 26 cases (with 34 hospital contacts) were registered 
with hospitalization due to infections. Five cases had more than one hospitalization due to 
infection. The diagnosis included bacterial sepsis in newborn (6 hospital contacts), 
unspecific virus infection (6 hospital contacts), laryngitis (4 hospital contacts) and 
respiratory infection (e.g. pneumonia and bronchitis) (6 hospital contacts). The median of 
the hospitalization time was 2 days (IQR 1-10). For the control group the similar median 
hospitalization time was 2 days (IQR 2-6).
A total of 42 cases (with 77 hospital contacts) were registered with hospitalization due to 
infection from age 1-5. Nine cases had more than one hospitalization due to infection. The 
diagnosis included gastroenteritis (12 hospital contacts), pneumonia (8 hospital contacts), 
bronchitis (5 hospital contacts), acute obstructive laryngitis (8 hospital contacts), 
pharyngitis (5 hospital contacts), acute and chronic middle ear infection (6 and 8 hospital 
contacts) and urinary tract infection (e.g. pyelonephritis and cystitis) (5 hospital contacts). 
The median of the hospitalization time was 2 days (IQR 1-3). For the control group the 
similar median hospitalization time was 2 days (IQR 2-3).
Furthermore, the average number of hospitalizations due to infection was observed to be 
higher in the exposed cohort compared with the non-exposed cohort for all age periods as 
shown in Table 2.  Additionally, the average number of antibiotic prescriptions filled 
between age one and five was also increased in exposed children (2.15 95%CI 1.65-2.65) 
compared with non-exposed children (1.49 95%CI 1.38-1.61).     
Figure 3 illustrates the cumulative incidence of hospitalization due to infection over time in 
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higher in the exposed cohort and the difference between the two groups increased in 
relation to time. 
3.1 Subgroup analyses
In subgroup analyses, outcomes in preterm children in the exposed cohort were compared 
with outcomes in preterm children of the non-exposed cohort.  Results are provided in 
Supplemental Table S2. Risk ratios for late hospitalizations due to infections (RR 2.02, 
95%CI 1.12-3.65) and the difference between average number pertaining to overall (RR 
0.61, 95%CI 0.03-1.20) and late number of infections (RR 0.61, 95%CI 0.23-0.98) continued 
to be significantly increased. Similarly, in the subgroup analysis with children born with low 
birth weight (Supplemental Table S3), the difference regarding average number of 
hospitalizations due to late infections also observed a borderline significant increase (RR 
0.43, 95%CI -0.01-0.88).
No significant differences were observed in a subgroup analysis of children to mothers with 
diabetes (Supplemental Table S4). In subgroup analyses comparing outcomes between 
different time periods (children born before 1996, from 1996 to 2010 and from 2010) 
(Supplemental Table S5, S6 and S7), results remained principally unchanged. No substantial 
differences were evident for hospitals employing a reduced prednisone compared with 
standard dose prednisone (Supplemental Table S8 and S9). No significant differences were 
observed in a subgroup analysis of children to mothers with hypertension (Supplemental 
Table S10). The most frequent anti-hypertensive treatment in our cohort of kidney-
transplanted mothers was beta-blockers, calcium antagonists and methyldopa 
(Supplemental Table S11). 
4. Discussion
The major new finding in this nationwide cohort study, was that children of kidney-
transplanted women are at increased risk of early as well as late infection. In addition, our 
results confirm the increased prevalence of low birth weight, preterm birth, and 
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The higher incidence of low weight children in the exposed cohort (37.9%) is similar to 
previous observations in other studies.8,9  Similarly, our results confirm an increased 
incidence of preterm birth of 46.0%, analogous to the increased incidences previously 
observed in smaller studies.5,8,9 
In a study from UK with 108 children of kidney-transplanted women, the prevalence of 
congenital anomaly was 5%.9 In our study, the prevalence of malformations was 11.3%; 
however, the difference compared with Bramham et al. (2013) may reflect differences in 
definitions of the outcome. Nonetheless, the increased risk for malformations plausibly 
reflects the toxic effects of immunosuppressive treatment in fetal life. Additionally, a 
substantial proportion of kidney-transplanted women require antihypertensive treatment 
prior to and during pregnancy. In our cohort 71% (88/124) of the children in the kidney-
transplanted cohort were exposed to maternal hypertension during pregnancy. As such, the 
exposure to hypertension could increase the risk for malformation, particularly in cases of 
unplanned pregnancy leading to delayed conversion of antihypertensive treatment to ‘safe’ 
medications.
A study from Brazil with 28 children of kidney-transplanted women showed a higher risk of 
hospital admission for infectious causes in the first year of life compared with controls 
(28.6% vs 3.6%, p=0.025).10 However, the study was of limited size and did not report long-
term risk of infection. We are not aware of other studies demonstrating the long-term risk 
for infections in offspring of kidney-transplanted women. 
To evaluate the risk of infection, our study evaluated both hospitalizations due to infections, 
indicating severe infections, and the use of prescription for antibiotic treatment. The 
exposed cohort observed a higher prevalence of both early (21.0%) and late hospitalization 
due to infections (34.2%) compared with the non-exposed cohort; specifically, children of 
kidney-transplanted women observed a 94% and 89% increased risk of hospitalization for 
treatment of infection during the first year of life and from age one to five years, respectively, 
compared with non-exposed children. Of note, no differences were observed regarding 
prescription of antibiotic treatment; however, this may reflect an overriding general use of 
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total number of hospitalizations due to infection and total number of prescriptions for 
antibiotics were also considered - thereby accounting for the possibility of repeated 
outcomes within the follow-up period. 
As such, children of kidney-transplanted women observed more frequent hospitalization due 
to infection during the first year, between ages one and five years, and overall. No difference 
was observed regarding prescription of antibiotics within the first year and overall; 
however, children of kidney-transplanted women did observe a more frequent requirement 
of prescription antibiotics between ages one to five years. 
To examine the impact of preterm birth and low birth weight on risk of infection, subgroup 
analyses were performed. Importantly, the subgroup analyses indicate that the increased 
risk ratios for infections, especially late infections, in children born by kidney-transplanted 
women remained independently of preterm birth and low birth weight. As such, our results 
indicate that risk of infection is at least somewhat independent of preterm birth and low 
birth weight. 
Plausibly, the greater predisposition for infection in offspring of kidney-transplanted women 
could be mediated by exposure to immunosuppressive treatment in fetal life. Central 
immunologic tolerance develops in the thymus in fetal life and can be affected by various 
immunosuppressive drugs. Animal studies have reported that immunosuppressive drugs 
can affect both the positive selection (selection of T cells that can recognize self-MHC 
molecules) and the negative selection (T cells that bind too strong to self-MHC class are 
signaled to die) in thymus in fetal life20. It is possible that the immunosuppressive drugs 
affect the positive selection, which becomes too strong or unspecific leading to a lack of T-
lymphocytes with specificity against bacterial antigens. Small studies in children exposed to 
immunosuppressive treatment in fetal life have shown lower numbers of T- and B-cells 
compared to controls.21,22 Similarly, a recent study with 28 children of kidney-transplanted 
women reported lower numbers of CD4+ T-cell, natural killer cells and intense reduction of 
B cells.10 This could perhaps explain the immunosuppressive effect on the immune system. 
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Additionally, kidney-transplanted mothers may infer possible inheritance of specific genetic 
dispositions, particularly with regard to immunology due to a predominance of a history of 
glomerulonephritis in young adults with end-stage renal disease. As such, the observed 
increase in risk of infection could also represent inherited immune vulnerability.
Exposure to immunosuppressive treatment in fetal life has in animal studies also been 
associated with an increased risk of autoimmune disease.23 In addition, a case report 
described several autoimmune diseases in a daughter of a kidney-transplanted woman 
treated with immunosuppression with azathioprine and prednisone during pregnancy.24 
Children exposed to immunosuppressive treatment in fetal life may therefore be at 
increased risk for developing autoimmune diseases. We were not able to evaluate the risk 
for autoimmune diseases in our study because of too few cases. This could, however, be 
influenced by the follow-up time (median follow-up time was 14.5 years). Long-term follow-
up is therefore necessary to explore the risk for autoimmune diseases in the offspring of 
kidney-transplanted women.
4.1 Strengths and weaknesses of the study
This nationwide controlled cohort study has several strengths. Most importantly, this may 
be the first study worldwide to investigate the long-term risk for infections in offspring of 
kidney-transplanted women. In addition, this study has the largest cohort of children born 
by kidney-transplanted women internationally with regard to infections.10  Piccoli et al. 
reported outcomes of 189 children born by kidney-transplanted women but only with 
regard to neonatal complications.8 
The study was not limited by selection- or recall bias as all offspring of all kidney-
transplanted women in Denmark were included, and data was retrieved from excellently 
validated national registers and not through questionnaires or retrospective interviews. 
Prior register-based studies on pregnancy outcomes in kidney-transplanted women employ 
the National Transplantation Pregnancy Register in the US, which is a voluntary database 
representing only 1/3 of all available information reported on pregnancy outcomes in 
kidney-transplanted women.5 The registries in Denmark are of high quality for 
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connect parents and children.13,14 Similarly, the NRDT is validated to be complete, of high 
quality and a good source for epidemiological studies.11 
A limitation concerning the exact immunosuppressive treatment is that this medicine is 
delivered directly from the hospital and is therefore not registered in The Danish National 
Prescription Registry. However, all kidney-transplanted women have received and continue 
to receive immunosuppressive treatment in accordance with international guidelines and 
the treatment is standardized in Denmark. Additionally, tax-funded health care is provided 
by law to all Danish citizens, and all kidney-transplanted procedures and follow-up is 
provided via 14 nephrology departments at accredited public hospitals without exception. 
Nonetheless, the study is unable to assess the impact of specific immunosuppressive 
protocols on the risk of neonatal complications and early- and late infection.
Breast feeding in transplanted mothers on immunosuppressive treatment 
remains controversial. Transference of maternal antibodies and immunosuppressants via 
breast milk varies, and significance is uncertain.3 The consensus opinion from the American 
Society of Transplantation in 2003 was however, that breastfeeding need not be viewed as 
absolutely contraindicated.3 Data is however limited, and as breast feeding status remains 
unaccounted for in our cohort of kidney-transplanted mothers, our results remain unable to 
assess the impact of breast feeding.
It could be argued, that children born by kidney-transplanted women are more exposed to 
clinical examinations than children born by healthy mothers. However, the outcomes 
preterm birth and birth weight are independent and registered for all children born in 
Denmark. In generally, all prescriptions of antibiotics in Denmark require an individual 
medical examination. Since the knowledge about long-term risk after immunosuppressive 
treatment in fetal life is very limited, this information is not considered to be of great 
importance in the clinical examination and it is assumed that children of kidney-
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Children born by kidney-transplanted women have an increased risk of neonatal 
complications and both early and late infections up to the age of five years. The increased 
risk for infections could be due to immunosuppressive exposure in fetal life; however, 
further research is needed to clarify the causation and possible mediation of specific 
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     < 1990
     1990-2000










     Boys







Number of siblings at birth, 
n(%)
          0
          1
          2 









Gestational age in days, 
mean (SD) 245.2 (22.6) 277.7 (22.6)
Birth weight in gram,
mean (SD) 
2421.6 (766.4) 3444.1 (569.1)
Birth length in cm,
mean (SD) 45.5 (8.5) 51.0 (6.6)
Head circumference in cm,
mean (SD) 
28.5 (11.0) 33.9 (5.9)
Abdominal circumference in 
cm, mean (SD) 
20.3 (14.6) 31.3 (8.8)
Weight of placenta in gram,
mean (SD) 
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Table 2. Average number of infections leading to hospital admission/antibiotics per child in 
non-exposed and exposed children, respectively, and the difference between the two groups. 
Both outcomes were evaluated overall (from birth to age 5), early (within the first year of 
life) and late (from age 4-5).











Overall infections 0.41 (0.36-0.46) 0.88 (0.61-1.15) 0.48 (0.20-0.75)
Early infections 0.14 (0.11-0.17) 0.28 (0.16-0.39) 0.14 (0.02-0.25)
Late infections 0.23 (0.20-0.27) 0.56 (0.37-0.74) 0.32 (0.13-0.51)
Overall antibiotics 2.24 (2.08-2.40) 2.88 (2.21-3.54) 0.64 (-0.05-1.32)
Early antibiotics 0.40 (0.35-0.45) 0.43 (0.27-0.59) 0.030 (-0.13-0.20)
Late antibiotics 1.49 (1.38-1.61) 2.15 (1.65-2.65) 0.66 (0.14-1.17)
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Figure 2. Prevalences and Risk Ratios for hospitalizations due to infections and redemptions 
of an antibiotic prescription. 
AB= antibiotic treatment. 
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Figure 3. Cumulative incidence with 95% CI of first hospitalization due to infection over 
time in children of kidney-transplanted mothers and unexposed mothers. 
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